TNK2 and juvenile myelomonocytic leukemia: In juvenile myelomonocytic leukemia (JMML) and AML cells, Ack1 activates PTPN11, and PTPN11-mutant JMML and AML cells are all sensitive to Ack1 inhibition [78].